|Tennessee Tech University, M.S.|
|Tennessee Tech University, B.S.|
Fred Khosravi is a Silicon Valley medical device entrepreneur who has co-founded multiple companies, including EndoTex, Embolic Protection, Inc. (EPI), both acquired by Boston Scientific Corporation, Confluent Surgical, acquired by Tyco Healthcare, and MarketRx, acquired by Cognizant Corp.
Additionally, he is the managing director of a medical device incubator called Incept.
In addition to Confluent, EPI, and AccessClosure, Incept has spawned several other novel device companies including Sadra Medical (acquired by Boston Scientific), Ostial Corp., HotSpur, Inc., and Ocular Therapeutix, Inc., where Fred serves as co-founder and Director/Chairman.
Fred also served on the boards of Kerberos before its acquisition by FoxHollow Technologies and Advanced Stent Technologies prior to its acquisition by Boston Scientific.
He holds a B.S. in mechanical engineering, and graduated summa cum laude, obtaining a M.S. in mechanical engineering from Tennessee Tech University.